More on Pall (NYSE:PLL-OLD): FQ2 misses on all counts despite an 8.2% Y/Y rise in revenue growth. Sales increased across all segments, with good growth in its Life Sciences and Industrial units. On a global basis, emerging market sales grew over 20% in local currency driven by the Energy markets in MENA and Latin America. Shares -1.9% AH.